Recruiting Lung Cancer Studies in Beijing
Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer
Indication:Patients with Advanced c-MET-positive Non-Small Cell Lung Cancer Phase Ib (China only): Approximately 90 patients Phase â…¡ (globally): Approximately 78 evaluable patients; addition of at...
Volrustomig Priming Regimens Exploratory Phase II Platform Study
Purpose of this study is to assess the safety, tolerability, pharmacokinetics, immunogenicity, and antitumor activity of volrustomig in combination with other anticancer drugs in participants with spe...
A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84)
Researchers are looking for new ways to treat non-small cell lung cancer (NSCLC) that is metastatic, which means cancer has spread to other parts of the body. Some people with metastatic NSCLC are tr...
Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer
This is a Phase 2b, multicenter, open-label study to evaluate the safety and efficacy of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC (Non-resistant Uncommon EGFR Mutations Only, ...
About Lung Cancer Clinical Trials in Beijing
Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.
There are currently 4 lung cancer clinical trials recruiting participants in Beijing, BEIJING%20MUNICIPALITY. These studies are seeking a combined 622 participants. Research is being sponsored by Haihe Biopharma Co., Ltd., AstraZeneca, Merck Sharp & Dohme LLC and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lung Cancer Clinical Trials in Beijing — FAQ
Are there lung cancer clinical trials in Beijing?
Yes, there are 4 lung cancer clinical trials currently recruiting in Beijing, BEIJING%20MUNICIPALITY. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Beijing?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Beijing research site will contact you about next steps.
Are clinical trials in Beijing free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Beijing studies also compensate for your time and travel.
What lung cancer treatments are being tested?
The 4 active trials in Beijing are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.
Data updated March 2, 2026 from ClinicalTrials.gov